image
Healthcare - Biotechnology - NASDAQ - US
$ 37.67
0.106 %
$ 3 B
Market Cap
-10.05
P/E
Price Target Average
22.11%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
20.76%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Akero Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for AKRO of $46 , with forecasts ranging from a low of $38 to a high of $56 .
AKRO Lowest Price Target Wall Street Target
38 USD 0.88%
AKRO Average Price Target Wall Street Target
46 USD 22.11%
AKRO Highest Price Target Wall Street Target
56 USD 48.66%
Price
Max Price Target
Min Price Target
Average Price Target
6060555550504545404035353030252520201515Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart AKRO

image
$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart AKRO

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart AKRO

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)20232023202420242025202520262026202720272028202820292029